Home Other Building Blocks 1-Butylimidazole

1-Butylimidazole

CAS No.:
4316-42-1
Catalog Number:
AG003E6O
Molecular Formula:
C7H12N2
Molecular Weight:
124.1836
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
98%(GC)
In Stock USA
United States
$46
- +
25g
98%(GC)
In Stock USA
United States
$64
- +
100g
98%(GC)
In Stock USA
United States
$140
- +
250g
98%(GC)
In Stock USA
United States
$271
- +
500g
98%(GC)
In Stock USA
United States
$503
- +
Product Description
Catalog Number:
AG003E6O
Chemical Name:
1-Butylimidazole
CAS Number:
4316-42-1
Molecular Formula:
C7H12N2
Molecular Weight:
124.1836
MDL Number:
MFCD00042753
IUPAC Name:
1-butylimidazole
InChI:
InChI=1S/C7H12N2/c1-2-3-5-9-6-4-8-7-9/h4,6-7H,2-3,5H2,1H3
InChI Key:
MCMFEZDRQOJKMN-UHFFFAOYSA-N
SMILES:
CCCCn1cncc1
EC Number:
224-335-9
NSC Number:
158165
UN Number:
2690
Properties
Complexity:
73.3  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
124.1g/mol
Formal Charge:
0
Heavy Atom Count:
9  
Hydrogen Bond Acceptor Count:
1  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
124.187g/mol
Monoisotopic Mass:
124.1g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
17.8A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.2  
Literature
Title Journal
Gas-phase behaviour of Ru(II) cyclopentadienyl-derived complexes with N-coordinated ligands by electrospray ionization mass spectrometry: fragmentation pathways and energetics. Rapid communications in mass spectrometry : RCM 20120815
Silver(I) complexes of 9-anthracenecarboxylic acid and imidazoles: synthesis, structure and antimicrobial activity. Dalton transactions (Cambridge, England : 2003) 20120607
Synthesis of mesomeric betaine compounds with imidazolium-enolate structure. Beilstein journal of organic chemistry 20120101
2,4-Bis[(3-butyl-imidazol-3-ium-1-yl)meth-yl]-1,3,5-trimethyl-benzene bis-(hexa-fluoro-phosphate). Acta crystallographica. Section E, Structure reports online 20110301
Investigation on solvation and protonation of meso-tetrakis(p-sulfonatophenyl)porphyrin in imidazolium-based ionic liquids by spectroscopic methods. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20091001
Synthesis of cationic single-isomer cyclodextrins for the chiral separation of amino acids and anionic pharmaceuticals. Nature protocols 20070101
Sum frequency generation study of the room-temperature ionic liquids/quartz interface. The journal of physical chemistry. B 20060330
Simple chip-based interfaces for on-line monitoring of supramolecular interactions by nano-ESI MS. Lab on a chip 20051001
Tuning of redox properties for the design of ruthenium anticancer drugs: part 2. Syntheses, crystal structures, and electrochemistry of potentially antitumor [Ru III/II Cl6-n(Azole)n]z(n = 3, 4, 6) complexes. Inorganic chemistry 20050919
Transition metal-stabilized arenium cations: protonation of arenes dihapto-coordinated to pi-basic metal fragments. Journal of the American Chemical Society 20040602
Synthesis of N-alkylated derivatives of imidazole as antibacterial agents. Bioorganic & medicinal chemistry letters 20030901
Adduct formation of methyltrioxorhenium with mono- and bidentate nitrogen donors: formation constants. Inorganic chemistry 20030630
CO(2) capture by a task-specific ionic liquid. Journal of the American Chemical Society 20020213
Properties